Literature DB >> 31365630

Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome.

Victor Barbosa Ribeiro1,2, Gislaine Satyko Kogure1, Iris Palma Lopes1, Rafael Costa Silva1, Daiana Cristina Chielli Pedroso1, Rui Alberto Ferriani1, Cristiana Libardi Miranda Furtado1, Rosana Maria Dos Reis1.   

Abstract

OBJECTIVE: To investigate the associations among visceral adiposity index (VAI), lipid accumulation product (LAP), body fat percentage (%), and android/gynoid ratio (A/G ratio) in women with polycystic ovary syndrome (PCOS) and verify if the parameters representative of visceral obesity correlate with and exhibit the same frequency as body composition variables; anthropometric indices; and metabolic, hormonal, and inflammatory parameters. SUBJECTS AND METHODS: This was a cross-sectional study that included 94 women with PCOS. Hormonal, metabolic, and inflammatory parameters were analyzed in all women. Free androgen index (FAI) and homeostasis model assessment (HOMA-IR), as well as LAP, VAI, and anthropometric indices, were calculated. The regions of interest (ROIs) in body composition and body composition indices were evaluated using a dual X-ray absorptiometry (DXA). Overall, 32 variables were selected as markers of body fat distribution.
RESULTS: Among the 32 markers evaluated, 29 correlated with LAP, whereas 25 correlated with VAI, 19 with body fat (%), and 30 with A/G ratio. Additionally, some markers correlated with the four adiposity indices evaluated: ROIs, except for total mass and leg fat (%); body composition (body mass index, waist circumference, and hip circumference) indices; fasting insulin; and C-reactive protein.
CONCLUSION: LAP and VAI may be sensitive measures for screening and preventing metabolic syndrome and insulin resistance in PCOS, with LAP being more sensitive than VAI, and the A/G ratio may be more sensitive than body fat percentage.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31365630     DOI: 10.20945/2359-3997000000157

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  2 in total

1.  Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index.

Authors:  Hurjahan Banu; Md Shahed Morshed; Tania Sultana; Sukanti Shah; Shazia Afrine; M A Hasanat
Journal:  J Hum Reprod Sci       Date:  2022-03-31

2.  Dose-Response Relationship of Resistance Training on Metabolic Phenotypes, Body Composition and Lipid Profile in Menopausal Women.

Authors:  Ana Carla Leocadio de Magalhães; Vilma Fernandes Carvalho; Sabrina Pereira da Cruz; Andrea Ramalho
Journal:  Int J Environ Res Public Health       Date:  2022-08-20       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.